(Total Views: 665)
Posted On: 05/15/2020 3:23:31 AM
Post# of 11803
Blood Glucose Sensor Patch Market to See Strong Investment Opportunity
https://surfacingmagazine.net/blood-glucose-s...-and-more/
Few of the major competitors currently working in blood glucose sensor patch market are Abbott, Apple Inc., Ascensia Diabetes Care Holdings AG, Cellnovo, Debiotech S.A., Glooko, Inc., Insulet Corporation, Johnson & Johnson Services, Inc., myDario.com, Medella Health Inc., Medtronic, Nemaura, Novo Nordisk India Pvt. Ltd., Onduo LLC, Pharma Tech Solutions , Inc., F. Hoffmann- La Roche Ltd, Sanofi, Tandem Diabetes Care, Inc.
https://surfacingmagazine.net/blood-glucose-s...-and-more/
Quote:
Global Blood Glucose Sensor Patch Market is expected to rise from its initial estimated value of USD 13.95 billion in 2018 to an estimated value of USD 30.41 billion by 2026, registering a CAGR of 10.23% in the forecast period of 2019-2026. Increase in the diabetic patient is the major factor for the growth of this market.
Few of the major competitors currently working in blood glucose sensor patch market are Abbott, Apple Inc., Ascensia Diabetes Care Holdings AG, Cellnovo, Debiotech S.A., Glooko, Inc., Insulet Corporation, Johnson & Johnson Services, Inc., myDario.com, Medella Health Inc., Medtronic, Nemaura, Novo Nordisk India Pvt. Ltd., Onduo LLC, Pharma Tech Solutions , Inc., F. Hoffmann- La Roche Ltd, Sanofi, Tandem Diabetes Care, Inc.
(3)
(0)
